Hangzhou Biotest Biotech Co Ltd (688767) - Total Liabilities

Latest as of March 2026: CN¥121.73 Million CNY ≈ $17.81 Million USD

Based on the latest financial reports, Hangzhou Biotest Biotech Co Ltd (688767) has total liabilities worth CN¥121.73 Million CNY (≈ $17.81 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see Hangzhou Biotest Biotech Co Ltd balance sheet assets.

Hangzhou Biotest Biotech Co Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Hangzhou Biotest Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688767 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Hangzhou Biotest Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hangzhou Biotest Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Sparebanken Sor OL:SOR	Norway	Nkr158.47 Billion
Mesnac Co Ltd SHE:002073	China	CN¥13.54 Billion
Santacruz Silver Mining Ltd. V:SCZ	Canada	CA$237.69 Million
Yangmei Chemical Co Ltd SHG:600691	China	CN¥11.32 Billion
Chengdu Hongqi Chain Co Ltd SHE:002697	China	CN¥3.48 Billion
CAP S.A SN:CAP	Chile	CL$2.90 Billion
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd SHG:688505	China	CN¥273.93 Million
Zhejiang Tony Electronic Co Ltd SHG:603595	China	CN¥3.24 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Hangzhou Biotest Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check 688767 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	14.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hangzhou Biotest Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hangzhou Biotest Biotech Co Ltd (2017–2025)

The table below shows the annual total liabilities of Hangzhou Biotest Biotech Co Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥168.17 Million ≈ $24.61 Million	-11.39%
2024-12-31	CN¥189.79 Million ≈ $27.77 Million	+19.50%
2023-12-31	CN¥158.82 Million ≈ $23.24 Million	-15.93%
2022-12-31	CN¥188.92 Million ≈ $27.64 Million	-41.58%
2021-12-31	CN¥323.36 Million ≈ $47.32 Million	+69.39%
2020-12-31	CN¥190.89 Million ≈ $27.93 Million	+125.92%
2019-12-31	CN¥84.50 Million ≈ $12.36 Million	+49.60%
2018-12-31	CN¥56.48 Million ≈ $8.27 Million	+17.96%
2017-12-31	CN¥47.88 Million ≈ $7.01 Million	--

About Hangzhou Biotest Biotech Co Ltd

SHG:688767 China Biotechnology

Market Cap

$889.82 Million

CN¥6.08 Billion CNY

Market Cap Rank

#9445 Global

#2358 in China

Share Price

CN¥40.72

Change (1 day)

+0.30%

52-Week Range

CN¥30.56 - CN¥48.37

All Time High

CN¥125.45